Investor: Bill Ackman

Investor, People

William Albert Ackman (born May 11, 1966) is an American investor and hedge fund manager. He is the founder and CEO of Pershing Square Capital Management, a hedge fund management company. Ackman has been considered an engaged activist investor, which is long-term in nature..

Ackman was raised in Chappaqua, New York, the son of Ronnie I. (née Posner) and Lawrence David Ackman, the chairman of a New York real estate financing firm, Ackman-Ziff Real Estate Group. Continue reading “Investor: Bill Ackman”

Article: 15 Hedge Fund Managers Made $23 Billion In 2020

Article - Media

15 Hedge Fund Managers Made $23 Billion In 2020

Tyler Durden, Zero Hedge, 10 February 2021

The historic gains by a handful of Wall Street tians demonstrates “the disconnect between the stock market and the real economy,” said finance professor Reena Aggarwal, director of Georgetown University’s Center for Financial Markets & Policy. While high volatility and low interest rates buoyed hedge funds, much of the population struggled “with worries about health, jobs, mortgage payments and student loans,” she said.

Read full article.

Article: Caught in a bear trap: How ‘short and distort’ attacks are costing Australian investors billions

Article - Media

Caught in a bear trap: How ‘short and distort’ attacks are costing Australian investors billions

Adele Ferguson

Sydney Morning Herald,

Australia has become a paradise for a new, aggressive form of short selling. And regulators’ failure to act is costing investors billions.

Dubbed the “short and distort” gang, a group of largely foreign-based research houses issue highly damaging reports, designed to cause maximum damage to the companies they target.

Read full article.

Article: Drugmaker Valeant CEO leaving as investor Ackman joins board

Article - Media, Publications

Drugmaker Valeant CEO leaving as investor Ackman joins board

Reuters, 21 March 2016

Drugmaker Valeant Pharmaceuticals International Inc (>> Valeant Pharmaceuticals Intl Inc) (>> Valeant Pharmaceuticals Intl Inc) said on Monday its chief executive officer is leaving and billionaire investor William Ackman would join the board as it tries to clean up accounting problems and save its business.
(Reuters) – Drugmaker Valeant Pharmaceuticals International Inc (>> Valeant Pharmaceuticals Intl Inc) (>> Valeant Pharmaceuticals Intl Inc) said on Monday its chief executive officer is leaving and billionaire investor William Ackman would join the board as it tries to clean up accounting problems and save its business. Continue reading “Article: Drugmaker Valeant CEO leaving as investor Ackman joins board”

Article: Valeant accused of ‘aggressive accounting games’ by renowned short-seller Jim Chanos

Article - Media, Publications

Valeant accused of ‘aggressive accounting games’ by renowned short-seller Jim Chanos

Nicolas Van Praet, 16 May 2014

Valeant Pharmaceuticals International Inc. teamed up with respected activist Bill Ackman to buy Allergan Inc. in part to build its own legitimacy with investors after several periods of short-selling in Valeant stock in recent years. So far, however, the partnership has done little to silence the most vocal voices betting against Canada’s largest drug company. Continue reading “Article: Valeant accused of ‘aggressive accounting games’ by renowned short-seller Jim Chanos”